Airports are testing algae-filled bioreactors as a biological alternative to conventional air filtration, targeting the headaches, fatigue, and respiratory irritation collectively known as sick building syndrome. The approach draws on peer-reviewed research showing that microalgae can absorb indoor carbon dioxide through photosynthesis, potentially improving air quality in enclosed, high-traffic terminals where traditional ventilation often falls short. Whether these living systems can scale from laboratory chambers to sprawling concourses remains an open question, but early federal funding and a growing body of experimental data suggest the concept is gaining traction.
What Sick Building Syndrome Actually Means
The term “sick building syndrome” gets tossed around loosely, but the health problems behind it are specific and well documented. Occupants of poorly ventilated buildings report clusters of symptoms: headaches, eye irritation, difficulty concentrating, and upper respiratory issues that ease once they leave the structure. In airport terminals, where thousands of travelers cycle through sealed environments every hour, the risk factors compound. Elevated CO2 from crowds, volatile organic compounds from cleaning products and jet fuel residue, and recirculated air all contribute.
The indoor air quality guidance from the World Health Organization ties these symptoms to dampness, mould, and inadequate ventilation, stressing prevention and moisture control over quick technological fixes. That framing matters because it sets a high bar for any new technology claiming to solve the problem. A bioreactor that lowers CO2 but ignores humidity, particulate matter, or microbial contamination would address only one piece of the puzzle. Regional WHO offices, including those serving African member states and the Eastern Mediterranean region, have echoed the need for better indoor environmental standards as urban density rises and more populations spend time in large enclosed transit hubs.
How Algae Bioreactors Actually Work Indoors
The core idea is straightforward: microalgae consume CO2 and release oxygen through photosynthesis, just as trees do outdoors. A photobioreactor encloses a culture of algae in a transparent vessel, feeds it light (natural or artificial), and channels indoor air through the liquid so the organisms can metabolize carbon dioxide. The result is a living filter that, unlike a standard HEPA unit, does not simply trap particles but chemically converts a key indoor pollutant into breathable oxygen.
A review in the journal Building and Environment surveys how these systems are being positioned as biological air purifiers for indoor CO2 control, examining pollutant types, photobioreactor configurations, and integration strategies. The authors treat photobioreactors not as a novelty but as a serious engineering option for enclosed spaces where mechanical ventilation alone cannot keep CO2 below comfort thresholds. That distinction is important: airports often recirculate air to save energy, which means CO2 concentrations can climb well above outdoor baselines during peak passenger loads, even when ventilation systems meet code.
Experimental work has moved beyond theory. A study in Applied Sciences tested a lab-scale photobioreactor using the species Spirulina maxima, measuring its carbon dioxide uptake inside a controlled chamber. The researchers detailed airflow, light intensity, culture density, and chamber conditions, then tracked how quickly the system drew down CO2 from elevated levels. Those results come from a tightly controlled setting rather than a live terminal, but they give engineers real numbers to work with when estimating how many units would be needed to stabilize air quality in larger spaces.
Follow-on work with similar setups has explored how culture density, reactor geometry, and lighting strategies influence CO2 removal efficiency, reinforcing the idea that performance is highly sensitive to design details. For airports, that sensitivity cuts both ways: a well-optimized system could offer meaningful air quality benefits with a modest footprint, while a poorly tuned one might deliver little improvement despite substantial cost and complexity.
Federal Funding Signals Institutional Interest
Lab papers alone do not move technology into airports. What does is money, and the U.S. federal government has started directing funds toward algae-based air treatment. The Environmental Protection Agency awarded a Phase I Small Business Innovation Research grant to the VerdeTerra HVAC concept, which aims to integrate photobioreactors directly into heating, ventilation, and air conditioning systems. The SBIR program is designed to push early-stage concepts through feasibility testing, and a Phase I award signals that the EPA considers the approach worth investigating, even if it has not yet been validated at commercial scale.
The VerdeTerra project targets indoor CO2 levels and other pollutants, positioning algae not as a replacement for conventional filters but as a complementary biological layer within existing HVAC infrastructure. That integration strategy matters because airports cannot rip out their mechanical systems overnight. Any viable solution needs to bolt onto current ductwork and air handling units without disrupting operations or violating safety codes. The SBIR award documentation outlines goals such as reducing energy use associated with outside air intake and enhancing pollutant removal, though full performance data from the project is not yet publicly available.
The Gap Between Lab Results and Terminal Reality
The biggest challenge facing algae bioreactors in airports is scale. A lab chamber measuring a few cubic meters bears little resemblance to a terminal concourse that may span hundreds of thousands of square feet and process tens of thousands of passengers daily. CO2 loads fluctuate with flight schedules, gate assignments, and seasonal travel patterns. A bioreactor sized for average occupancy could be overwhelmed during holiday rushes, while one sized for peak loads would be oversized and costly during off-peak hours.
Engineers also have to contend with air distribution. In a laboratory, air passes directly through the photobioreactor, and sensors can verify uniform mixing. In an airport, air moves through complex paths shaped by architectural features, passenger movement, and existing ventilation systems. If bioreactors are tucked into mechanical rooms or mounted along a few walls, their impact may be highly localized, leaving pockets of stale air where travelers actually spend their time. Integrating these systems into central air handling units could offer more even coverage but would require careful coordination with building management systems and regulatory approvals.
Maintenance adds another layer of complexity. Algae cultures need consistent light, temperature, and nutrient levels to stay productive. If a culture crashes due to contamination, biofouling, or nutrient depletion, the bioreactor becomes dead weight until it is re-seeded and regrown. Airport operations teams already juggle thousands of maintenance tasks, from jet bridges to baggage systems; adding biological systems that require specialized care is a real operational burden. Questions about who maintains the cultures, how often they are harvested or replaced, and how to dispose of biomass safely will need clear answers before large-scale deployment.
There is also the question of what algae bioreactors do not fix. The WHO guidelines emphasize that sick building syndrome involves dampness, mould, and a range of chemical pollutants beyond CO2. A photobioreactor that excels at carbon dioxide absorption but does nothing about volatile organic compounds, particulate matter, or microbial growth would leave most of the problem untouched. Some researchers have suggested that certain algae species can metabolize VOCs as well, but the evidence remains limited compared with the robust data on CO2 uptake, and airports still must comply with strict standards for particulate filtration and pathogen control.
Where Airports Might Start
Given these constraints, early airport deployments are likely to be pilots rather than full-terminal retrofits. Smaller, high-visibility areas such as airline lounges, crew rest zones, or conference facilities could serve as test beds. These spaces are easier to isolate, instrument, and monitor, allowing operators to compare CO2 levels, occupant comfort surveys, and energy use before and after installation. Data from such pilots could help determine whether algae systems meaningfully reduce symptoms associated with sick building syndrome or primarily offer marginal gains over improved mechanical ventilation.
Another plausible starting point is integration into back-of-house mechanical rooms, where bioreactors can treat a portion of return air before it is mixed and supplied to occupied zones. This approach would keep most of the biological equipment out of public view while letting facility managers experiment with control strategies, maintenance routines, and emergency procedures. If performance proves reliable and cost-effective, airports could gradually expand coverage, targeting gates or concourses with known air quality challenges.
A Complement, Not a Cure-All
For now, algae bioreactors should be viewed less as a silver bullet for sick building syndrome and more as a potential complement to established measures. The WHO’s emphasis on basic building hygiene, moisture control, and adequate ventilation remains the foundation of healthy indoor environments. Within that framework, photobioreactors could offer airports an additional tool: a way to shave CO2 peaks, offset some ventilation energy costs, and signal a commitment to innovative, low-carbon infrastructure.
Whether that promise translates into widespread adoption will depend on the results of ongoing research and early pilots. Airports, regulators, and technology developers will have to weigh the measurable benefits in air quality and passenger comfort against the practical realities of installing, operating, and maintaining living systems at scale. Until those data are in hand, algae-filled bioreactors will remain an intriguing, biologically elegant idea, one that hints at a future where the air inside busy terminals is cleaned not just by fans and filters, but by microscopic organisms quietly photosynthesizing behind the walls.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
